Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2025-07-22 Capital/Financing Update
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득 (제4회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from NKMAX regarding the acquisition of bonds before maturity (specifically, Bond with Warrant/BW). It details the acquisition of the 4th series of bonds, the amount, the reason (repayment due to rehabilitation plan), and the method of disposal (cancellation). This falls under capital structure changes and financing activities, specifically related to debt management and capital adjustments.
2025-07-22 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제11회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from NKMAX regarding the acquisition of convertible bonds before maturity (early redemption/buyback). It details the bond series, acquisition amount, reason (rehabilitation plan), and method. This falls under capital structure changes and financing updates, specifically related to debt management, which is best categorized as CAP (Capital/Financing Update).
2025-07-22 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from NKMAX regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). It details the specific bond series (13th), the acquisition amount, the reason (repayment of rehabilitation claims), and the method of disposal (cancellation). This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best classified as CAP (Capital/Financing Update).
2025-07-22 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제14회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from NKMAX regarding the acquisition of convertible bonds before maturity (14th series). It details the bond type, acquisition amount, acquisition date, and the reason for acquisition (repayment of rehabilitation claims). This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best classified as CAP (Capital/Financing Update).
2025-07-22 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by Meritz Securities and its special related parties in NKMAX Co., Ltd. due to corporate actions like stock consolidation and capital increases. This falls under the category of 'Major Shareholding Notification' (MRQ).
2025-07-11 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership due to a corporate rehabilitation plan (capital reduction). This falls under the category of Major Shareholding Notification as it tracks significant ownership thresholds and changes.
2025-07-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.